AI: The Next Revolution In Medicine?

Jan 23, 2019

AI: The Next Revolution In Medicine?

Watch our CEO, Joanna Shields, as she takes the stage and returns to DLD 2019 - an event which is a source of great inspiration and hope.

Given the state of the world today, at BenevolentAI we think we could all benefit from a giant dose of optimism. We believe that unconventional thinking combined with purposeful technology can truly change outcomes in the world. And that is what Joanna touches upon during her talk to the audience at DLD.

Tagged:

More Posts

You Might Also Like

Tech Nation Visa: the gateway to world-leading UK tech jobs

Drawing attention to the Tech Nation Visa, a great initiative that enables the brightest international talent to live and work in the UK.

Feb 19, 2021

BenevolentAI announces first patient dosed in its Atopic Dermatitis clinical trial

A molecule designed and developed by BenevolentAI to treat mild to moderate Atopic Dermatitis has entered clinical trials.

Feb 11, 2021

BenevolentAI and AstraZeneca achieve collaboration milestone with novel AI-generated chronic kidney disease target

BenevolentAI and AstraZeneca hit collaboration milestone with an AI-generated CKD target from the partnership entering AstraZeneca’s portfolio.

Jan 27, 2021

ACTT-2 trial results published in the New England Journal of Medicine validate baricitinib’s efficacy in combination with remdesivir in hospitalised COVID-19 patients

Peer-reviewed data from the ACTT-2 further validate BenevolentAI’s hypothesis for baricitinib as a potential COVID-19 treatment.

Jan 15, 2021

Joanna Shields speaks at the Global Partnership on Artificial Intelligence

BenevolentAI CEO Joanna Shields opened the final plenary of the Global Partnership on Artificial Intelligence (GPAI) summit with a powerful message on the future of AI.

Dec 11, 2020

BenevolentAI wins Innovation Award at 2020 Scrip Awards

BenevolentAI wins the Innovation Award at the prestigious 2020 Scrip Awards for our work in artificial intelligence applied drug discovery.

Dec 11, 2020